Information

  • Home
  • Call for Paper

Call For Papers

The ICPYDCAT bridges the gap between academia and industry by promoting research with practical applications. It provides a platform for professionals and researchers to share insights that drive real-world impact.

The conference focuses on Medical Ethics, Pharmacy, Bioinformatics, Medicine And Medical Science, encouraging applied research, case studies, and industry-driven innovations.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Classification systems for pharmaceutical products
  • Regulatory aspects of drug categorization
  • Impact of drug categories on prescribing
  • Pharmacy practice and drug classification
  • Trends in over-the-counter medications
  • Pharmaceutical care for chronic conditions
  • Role of pharmacists in drug education
  • Drug categorization and public health
  • Pharmacological profiles of new drugs
  • Patient perspectives on drug categories
  • Innovations in drug classification systems
  • Challenges in drug labeling and marketing
  • Pharmacy's role in drug safety education
  • Impact of drug categories on access
  • Ethical considerations in drug classification
  • Pharmacy-led initiatives for drug awareness
  • Global perspectives on drug categorization
  • Pharmaceutical policy and drug classification
  • Future of drug categorization in pharmacy
  • Pharmacovigilance and drug classification

Evaluation

Submissions will be evaluated based on applicability, innovation, and research contribution. Accepted papers will be presented and considered for publication in relevant journals and proceedings.

Registration

Complete your registration to participate in discussions that bridge academia and industry, and gain exposure to practical insights.

Publication

Selected papers will be considered for publication platforms that support academic and industry collaboration.

Conference Alert

Due to heightened regional tensions and travel risks, the conference may be conducted in virtual-only mode. Updates regarding participation format will be communicated in advance.